Therapeutic targeting of neuropilin-2 on colorectal carcinoma cells implanted in the murine liver. - Wikidata - wikimedia - TriplyDB

Therapeutic targeting of neuropilin-2 on colorectal carcinoma cells implanted in the murine liver.

Therapeutic targeting of neuropilin-2 on colorectal carcinoma cells implanted in the murine liver.

http://www.wikidata.org/entity/Q46817255

about

Neuropilin-2 expression in breast cancer: correlation with lymph node metastasis, poor prognosis, and regulation of CXCR4 expression The dicey role of Dicer: implications for RNAi therapy Neuropilins: expression and roles in the epithelium Enhancing integrin function by VEGF/neuropilin signaling: implications for tumor biology Preclinical and clinical development of siRNA-based therapeutics Neuropilin-2 mediated β-catenin signaling and survival in human gastro-intestinal cancer cell lines Vascular endothelial growth factor as an anti-angiogenic target for cancer therapy VEGF/neuropilin-2 regulation of Bmi-1 and consequent repression of IGF-IR define a novel mechanism of aggressive prostate cancer Neuropilin-2 Regulates Endosome Maturation and EGFR Trafficking to Support Cancer Cell Pathobiology.VEGF targets the tumour cell.Use of Nanotechnology to Develop Multi-Drug Inhibitors For Cancer Therapy Neuropilin-2 expression promotes TGF-β1-mediated epithelial to mesenchymal transition in colorectal cancer cells.A mutated soluble neuropilin-2 B domain antagonizes vascular endothelial growth factor bioactivity and inhibits tumor progression Efficient and targeted delivery of siRNA in vivo.Recent In Vivo Evidences of Particle-Based Delivery of Small-Interfering RNA (siRNA) into Solid Tumors Analysis of gene expression during mineralization of cultured human periodontal ligament cells miR-331-3p regulates expression of neuropilin-2 in glioblastoma.Neuroblastoma-targeted nanoparticles entrapping siRNA specifically knockdown ALK.Chemoresistant colorectal cancer cells, the cancer stem cell phenotype, and increased sensitivity to insulin-like growth factor-I receptor inhibition.Identification of cancer stem cells in human gastrointestinal carcinoid and neuroendocrine tumors.Hypoxia induces tumor and endothelial cell migration in a semaphorin 3F- and VEGF-dependent manner via transcriptional repression of their common receptor neuropilin 2.Biomarkers in tumor angiogenesis and anti-angiogenic therapy.Targeting angiogenesis in esophagogastric adenocarcinoma.Selective therapeutic targeting of the anaplastic lymphoma kinase with liposomal siRNA induces apoptosis and inhibits angiogenesis in neuroblastoma The emerging role of the thrombin receptor (PAR-1) in melanoma metastasis--a possible therapeutic target.Neuropilin-2 Is a Newly Identified Target of PAX8 in Thyroid Cells.Neuropilin-2 regulates α6β1 integrin in the formation of focal adhesions and signaling.Formulation Strategies, Characterization, and In Vitro Evaluation of Lecithin-Based Nanoparticles for siRNA Delivery.Targeting the urokinase plasminogen activator receptor with a monoclonal antibody impairs the growth of human colorectal cancer in the liver.Toward personalized cancer nanomedicine - past, present, and future.Identification of FGFR4 as a potential therapeutic target for advanced-stage, high-grade serous ovarian cancer GLI1 regulates a novel neuropilin-2/α6β1 integrin based autocrine pathway that contributes to breast cancer initiation.Intracrine VEGF Signaling Mediates the Activity of Prosurvival Pathways in Human Colorectal Cancer Cells.Targeting melanoma growth and metastasis with systemic delivery of liposome-incorporated protease-activated receptor-1 small interfering RNA.Semaphorins and their receptors in lung cancer.Neuropilin-2 promotes extravasation and metastasis by interacting with endothelial α5 integrin Concepts in in vivo siRNA delivery for cancer therapy.Synergistic activity of the SRC family kinase inhibitor dasatinib and oxaliplatin in colon carcinoma cells is mediated by oxidative stress Use of liposomes as drug delivery vehicles for treatment of melanoma.Metastasis regulation by PPARD expression in cancer cells.

P2860

Q21260387-58F8B87C-C45C-4AF6-99CD-9766918B9B05 Q24597854-5DE9E070-CE3B-4F92-B306-A860EA75A242 Q26998786-FF668F43-B01E-43C6-8B75-45EDF674D072 Q27022814-D9A06761-8561-4AFB-8836-63F17AAEA199 Q28085290-6DE41933-112C-414C-B20D-668169DAFBED Q28743682-A46F268C-FFA3-4884-8E09-7B1E203A6036 Q30455612-4EFC868B-68E2-430A-8D4B-E808E23737E8 Q30595149-CC2A1E84-8B81-4C2F-80EF-75E528C96762 Q30699331-EA925094-BF5E-44F2-8001-2DD3FE326C19 Q33573324-2AD95706-C9A3-4D34-ABB3-1AC22779AC7C Q33859472-CBA2936E-34A8-4192-ABAF-6368EE40CB1E Q33957987-AA4C8C53-3EAF-48F3-805D-DAB2BD302A2F Q34073272-556F2B80-21A6-4244-9C76-C9CD4266ED2D Q34149828-50340C3C-CEF5-4ECA-A1AB-84E88A5201D8 Q34165321-C9023617-5DFC-4594-9DB7-D04C05753D96 Q34634583-01791D44-BB83-444E-AF7A-3739338A87C0 Q35021427-7601BE4B-E862-4BA4-952D-9A8188BCDB53 Q35086721-0046E1ED-9707-4740-A42D-204FDB53890F Q35415181-0812107B-89F7-43F9-A3D6-5E15C3CDEDC7 Q35456945-65B565AD-0D0C-4093-99C4-2982B89BC76E Q35533847-501F4CD0-DACD-4589-BEF1-28B9D6CE174F Q35536088-4D8CA8F6-9DE3-4EEF-AFEF-F1001268A7C3 Q35584958-A38D0425-6626-4D23-87E0-CB304DB4F81D Q35623435-E4387496-495E-476C-BEBE-9DE57F470E33 Q35640140-23817AAB-B98E-48EB-AE17-3489B04E7C7F Q35647754-328F1DC3-D8A3-49B9-BA02-28C5753BD507 Q35770239-B16B6EA7-48A5-47E6-870C-3EE780587263 Q35909205-7BA16B8A-3F41-495F-84B6-1B32A9EC0D17 Q36168520-8768666B-358F-4D6C-8123-054922ACA42F Q36472802-5549A0C7-C2A5-47CA-AFC4-839C535D59C8 Q36625238-001C8A1D-8125-43DC-9224-A1F3FDCC742D Q36771302-6AC2A075-4DA7-4410-A9C9-243F6B86E34D Q36918194-363D3739-E960-40D1-AA02-390D1AEBE01C Q37001800-CB1E9B67-714F-4B75-BA4D-AA47287BD35F Q37072227-9A541C4B-441F-4A8F-BAD6-E50ABBC3EE0D Q37175886-DBA11F69-CC1A-4F6E-B170-8E938339DCB9 Q37217876-9E9C0227-4119-4EA9-806B-F2FC224F135F Q37259527-08C442EC-ADF2-4639-92D2-4455BADF5693 Q37406217-4B7E0876-763A-4D93-8466-1BCE82652A09 Q37559645-BD9ADAF2-221A-4687-B91F-32F4457BC2FC

P2860

Therapeutic targeting of neuropilin-2 on colorectal carcinoma cells implanted in the murine liver.

http://www.wikidata.org/entity/Q46817255

description

2008 nî lūn-bûn

@nan

2008年の論文

@ja

2008年学术文章

@wuu

2008年学术文章

@zh

2008年学术文章

@zh-cn

2008年学术文章

@zh-hans

2008年学术文章

@zh-my

2008年学术文章

@zh-sg

2008年學術文章

@yue

2008年學術文章

@zh-hant

name

Therapeutic targeting of neuro ...... implanted in the murine liver.

@en

Therapeutic targeting of neuro ...... implanted in the murine liver.

@nl

type

label

Therapeutic targeting of neuro ...... implanted in the murine liver.

@en

Therapeutic targeting of neuro ...... implanted in the murine liver.

@nl

prefLabel

Therapeutic targeting of neuro ...... implanted in the murine liver.

@en

Therapeutic targeting of neuro ...... implanted in the murine liver.

@nl

P1433

Q46817255-1C80E749-11FB-496C-947E-83930F005231

P1476

Q46817255-971B06F7-8085-4267-9A27-808771B0713D

P2093

Q46817255-2281B9B9-7DCB-4934-BC4E-DA2FD2BD6740

Q46817255-286C2D72-B846-4B99-A5AA-F05749129C8C

Q46817255-2B475EDF-0E79-47D2-B97F-FCD77F53F800

Q46817255-2B8FD983-9AFB-4403-AE97-14F5FCF648CF

Q46817255-33C86200-5F18-49A4-8A46-33F5A8DDD38B

Q46817255-344A3666-992E-4C82-9EA6-A040CF391F76

Q46817255-348C7067-C24A-40AA-9F4E-B72A76C8976F

Q46817255-53559C95-A91F-4C0E-941B-D011BD403BD9

Q46817255-70D15B4E-A197-4ECA-94E4-D964874FCDA0

Q46817255-A4610CE7-A7E0-4716-930F-9DC32BAF07B0

P2860

Q46817255-0FB6466B-8726-4E49-AFED-E696D7CCA49B

Q46817255-105578C4-EF6F-4A20-8EE3-B8CCDDE8B19F

Q46817255-17BC88BF-6C24-47AB-B0A5-39A294B25B42

Q46817255-3CDD2CD8-5979-43A8-A2DE-70A0C70A7A52

Q46817255-3DB4E1F0-5DB0-49E3-A6F9-2F09F6BC2A2F

Q46817255-506ADBE9-0A70-4EDA-AC29-ED36C212604F

Q46817255-56767FDB-6899-462D-8E61-37CFB4B43B49

Q46817255-67F35E49-6462-4A4F-ABCE-7428161ED121

Q46817255-69377554-107F-4BC2-981D-006928F70FDE

Q46817255-78118BFD-827D-40B2-B685-18C7BE7E4EE7

P304

Q46817255-3167D763-4273-4A94-8DA2-52CAEF5C6BA7

P31

Q46817255-DB60E588-FA13-429A-BA2E-A2176185A6FF

P356

Q46817255-FB6E5E7D-5545-4CCD-905F-92D0F560F32F

P407

Q46817255-DA0512DF-C005-4ED1-84B5-8A172568EE6C

P433

Q46817255-08B0F81F-4F03-4510-8953-ACDFE81F2C02

P478

Q46817255-47479CD6-15CD-4C9E-A214-3C180F4A3978

P577

Q46817255-DDF6B70C-7543-4CDA-8640-9285B246A9A2

P5875

Q46817255-D4CFB604-5D2D-421C-BB4F-EB131E4A8FFB

P698

Q46817255-57A04A38-5C42-4B5C-8BD9-D80D88361E86

P356

P1433

Journal of the National Cancer Institute

P1476

Therapeutic targeting of neuro ...... implanted in the murine liver.

@en

P2093

Anil K Sood

http://www.w3.org/2001/XMLSchema#string

Anthony D Yang

http://www.w3.org/2001/XMLSchema#string

Craig D Logsdon

http://www.w3.org/2001/XMLSchema#string

Fan Fan

http://www.w3.org/2001/XMLSchema#string

Gabriel Lopez-Berestein

http://www.w3.org/2001/XMLSchema#string

George Van Buren

http://www.w3.org/2001/XMLSchema#string

Lee M Ellis

http://www.w3.org/2001/XMLSchema#string

Ling Xia

http://www.w3.org/2001/XMLSchema#string

Lingegowda S Mangala

http://www.w3.org/2001/XMLSchema#string

Michael J Gray

http://www.w3.org/2001/XMLSchema#string

P2860

Vascular endothelial growth factor regulates endothelial cell survival through the phosphatidylinositol 3'-kinase/Akt signal transduction pathway. Requirement for Flk-1/KDR activation

Blocking neuropilin-1 function has an additive effect with anti-VEGF to inhibit tumor growth

Vascular endothelial growth factor receptor-1 promotes migration and invasion in pancreatic carcinoma cell lines

Neuropilin is a receptor for the axonal chemorepellent Semaphorin III

The biology of VEGF and its receptors

Neuropilin-2, a novel member of the neuropilin family, is a high affinity receptor for the semaphorins Sema E and Sema IV but not Sema III

The interaction of neuropilin-1 with vascular endothelial growth factor and its receptor flt-1

Vascular endothelial growth factor receptor-2 and neuropilin-1 form a receptor complex that is responsible for the differential signaling potency of VEGF(165) and VEGF(121)

Neuropilin-1 in human colon cancer: expression, regulation, and role in induction of angiogenesis

The kit receptor promotes cell survival via activation of PI 3-kinase and subsequent Akt-mediated phosphorylation of Bad on Ser136

P304

109-120

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/JNCI/DJM279

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

100

http://www.w3.org/2001/XMLSchema#string

P577

2008-01-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5667034

http://www.w3.org/2001/XMLSchema#string

P698

18182619

http://www.w3.org/2001/XMLSchema#string